Literature DB >> 22282661

BMK1 kinase suppresses epithelial-mesenchymal transition through the Akt/GSK3β signaling pathway.

Runqiang Chen1, Qingkai Yang, Jiing-Dwan Lee.   

Abstract

Epithelial-mesenchymal transition (EMT) plays a crucial role in the development of cancer metastasis. The mitogen-activated protein (MAP) kinases extracellular signal-regulated kinase, c-jun-NH(2)-kinase, and p38 have been implicated in promoting EMT, but a role for the MAP kinase BMK1 has not been studied. Here, we report that BMK1 signaling suppresses EMT. BMK1 elevation augmented E-cadherin-mediated cell-cell adhesion, downregulated mesenchymal markers, and decreased cell motility. Conversely, BMK1 silencing attenuated E-cadherin-mediated cell-cell adhesion, upregulated mesenchymal markers, and stimulated cell motility. BMK1 depletion dramatically increased the accumulation of endogenous Snail in the nuclear compartment. Snail accumulation was mediated by Akt/GSK3β signaling, which was activated by a modulation in the expression of the mTOR inhibitor DEPTOR. In support of these observations, BMK1 depletion promoted metastasis in vivo. Together, our findings reveal a novel mechanism of EMT control via mTOR/Akt inhibition that suppresses cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282661      PMCID: PMC3306490          DOI: 10.1158/0008-5472.CAN-11-2055

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.

Authors:  Xianhui Wang; Mingzhe Zheng; Gang Liu; Weiya Xia; Paula J McKeown-Longo; Mien-Chie Hung; Jihe Zhao
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 3.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

4.  Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

Authors:  Jesse S Boehm; Jean J Zhao; Jun Yao; So Young Kim; Ron Firestein; Ian F Dunn; Sarah K Sjostrom; Levi A Garraway; Stanislawa Weremowicz; Andrea L Richardson; Heidi Greulich; Carly J Stewart; Laura A Mulvey; Rhine R Shen; Lauren Ambrogio; Tomoko Hirozane-Kishikawa; David E Hill; Marc Vidal; Matthew Meyerson; Jennifer K Grenier; Greg Hinkle; David E Root; Thomas M Roberts; Eric S Lander; Kornelia Polyak; William C Hahn
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

Review 5.  TOR regulation of AGC kinases in yeast and mammals.

Authors:  Estela Jacinto; Anja Lorberg
Journal:  Biochem J       Date:  2008-02-15       Impact factor: 3.857

Review 6.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

7.  Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1.

Authors:  John F Alcorn; Amy S Guala; Jos van der Velden; Brian McElhinney; Charles G Irvin; Roger J Davis; Yvonne M W Janssen-Heininger
Journal:  J Cell Sci       Date:  2008-03-11       Impact factor: 5.285

Review 8.  Defining the role of mTOR in cancer.

Authors:  David A Guertin; David M Sabatini
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

9.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

Authors:  Marta Pàez-Ribes; Elizabeth Allen; James Hudock; Takaaki Takeda; Hiroaki Okuyama; Francesc Viñals; Masahiro Inoue; Gabriele Bergers; Douglas Hanahan; Oriol Casanovas
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

View more
  29 in total

1.  miR-429 inhibits glioma invasion through BMK1 suppression.

Authors:  Weiyi Chen; Baogang Zhang; Wenjun Guo; Linlin Gao; Lihong Shi; Hongli Li; Shijun Lu; Yuqing Liu; Xiaolong Li
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

Review 2.  Update in lung cancer and mesothelioma 2012.

Authors:  Charles A Powell; Balazs Halmos; Serge P Nana-Sinkam
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

Review 3.  Oncogenic signaling of MEK5-ERK5.

Authors:  Van T Hoang; Thomas J Yan; Jane E Cavanaugh; Patrick T Flaherty; Barbara S Beckman; Matthew E Burow
Journal:  Cancer Lett       Date:  2017-01-30       Impact factor: 8.679

4.  Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal.

Authors:  Cheng Fang; Ziqiang Zhang; Chaoxu Liu; Gang Wang; Fei Wang; Zhanwei Zhao; Wenhui Li; Jin Hua; Jianbo Shuang; Jianjun Du
Journal:  Dig Dis Sci       Date:  2016-03-26       Impact factor: 3.199

5.  Vitamin C inhibit the proliferation, migration and epithelial-mesenchymal-transition of lens epithelial cells by destabilizing HIF-1α.

Authors:  Lin Zhao; Yanlong Quan; Jianming Wang; Feng Wang; Yuping Zheng; Aiyi Zhou
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

Authors:  Yijiang Shi; Tracy R Daniels-Wells; Patrick Frost; Jihye Lee; Richard S Finn; Carolyne Bardeleben; Manuel L Penichet; Michael E Jung; Joseph Gera; Alan Lichtenstein
Journal:  Cancer Res       Date:  2016-08-16       Impact factor: 12.701

Review 7.  DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Authors:  Zhiwei Wang; Jiateng Zhong; Daming Gao; Hiroyuki Inuzuka; Pengda Liu; Wenyi Wei
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

8.  Overexpression and biological function of MEF2D in human pancreatic cancer.

Authors:  Zhiwang Song; Chan Feng; Yonglin Lu; Yong Gao; Yun Lin; Chunyan Dong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 9.  An evolving role for DEPTOR in tumor development and progression.

Authors:  Zhiwei Wang; Jiateng Zhong; Hiroyuki Inuzuka; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

10.  ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Authors:  Laura Arias-González; Inmaculada Moreno-Gimeno; Antonio Rubio del Campo; Leticia Serrano-Oviedo; María Llanos Valero; Azucena Esparís-Ogando; Miguel Ángel de la Cruz-Morcillo; Pedro Melgar-Rojas; Jesús García-Cano; Francisco José Cimas; María José Ruiz Hidalgo; Alfonso Prado; Juan Luis Callejas-Valera; Syong Hyun Nam-Cha; José Miguel Giménez-Bachs; Antonio S Salinas-Sánchez; Atanasio Pandiella; Luis del Peso; Ricardo Sánchez-Prieto
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.